https://www.selleckchem.com/products/dmx-5084.html This study aims to inform SARS-CoV-2 vaccine development/licensure/decision-making/implementation, using mathematical modeling, by determining key preferred vaccine product characteristics and associated population-level impacts of a vaccine eliciting long-term protection. A prophylactic vaccine with efficacy against acquisition (VES) ≥70% can eliminate the infection. A vaccine with VES less then 70% may still control the infection if it reduces infectiousness or infection duration among those vaccinated who acquire the infection, if it is supplemented with less then 20% reduction in contact rate, or if it is complemented with herd-immunity. At VES of 50%, the number of vaccinated persons needed to avert one infection is 2.4, and the number is 25.5 to avert one severe disease case, 33.2 to avert one critical disease case, and 65.1 to avert one death. The probability of a major outbreak is zero at VES ≥70% regardless of the number of virus introductions. However, an increase in social contact rate among those vaccinated (behavior compensation) can undermine vaccine impact. In addition to the reduction in infection acquisition, developers should assess the natural history and disease progression outcomes when evaluating vaccine impact.A new tactile sensing module was proposed to sense the contact force and location of an object on a robot hand, which was attached on the robot finger. Three air pressure sensors are installed at the tip of the finger to detect the contacting force at the points. To obtain a nominal contact force at the finger from data from the three air pressure sensors, a force estimation was developed based upon the learning of a deep neural network. The data from the three air pressure sensors were utilized as inputs to estimate the contact force at the finger. In the tactile module, the arrival time of the air pressure sensor data has been utilized to recognize the contact point of the robot finger